These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30001785)

  • 21. Diagnosis and Management of Osteoporosis.
    Jeremiah MP; Unwin BK; Greenawald MH; Casiano VE
    Am Fam Physician; 2015 Aug; 92(4):261-8. PubMed ID: 26280231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening and treatment of osteoporosis after hip fracture: comparison of sex and race.
    Antonelli M; Einstadter D; Magrey M
    J Clin Densitom; 2014; 17(4):479-83. PubMed ID: 24657109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Usefulness of FRAX tool for the management of osteoporosis in the Spanish female population].
    Azagra Ledesma R; Prieto-Alhambra D; Encabo Duró G; Casado Burgos E; Aguyé Batista A; Díez-Pérez A;
    Med Clin (Barc); 2011 May; 136(14):613-9. PubMed ID: 21349558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of osteoporotic fractures in the group of woman over 50 years of age--comparison of tools FRAX BMD versus FRAX BMI].
    Strugala C; Sobala W; Szubert Z; Hanke W
    Med Pr; 2013; 64(3):327-33. PubMed ID: 24261246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of electronic and manual fracture risk assessment tools in screening elderly male US veterans at risk for osteoporosis.
    Williams ST; Lawrence PT; Miller KL; Crook JL; LaFleur J; Cannon GW; Nelson RE
    Osteoporos Int; 2017 Nov; 28(11):3107-3111. PubMed ID: 28756457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Osteoporosis in men: underappreciated and undertreated].
    Zikán V
    Vnitr Lek; 2021; 67(5):271-283. PubMed ID: 35459393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of Trabecular Bone Score (TBS) as a Complementary Approach to Dual-energy X-ray Absorptiometry (DXA) for Fracture Risk Assessment in Clinical Practice.
    Shevroja E; Lamy O; Kohlmeier L; Koromani F; Rivadeneira F; Hans D
    J Clin Densitom; 2017; 20(3):334-345. PubMed ID: 28734710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multidisciplinary Portuguese recommendations on DXA request and indication to treat in the prevention of fragility fractures.
    Marques A; Rodrigues AM; Romeu JC; Ruano A; Barbosa AP; Simões E; Águas F; Canhão H; Alves JD; Lucas R; Branco JC; Laíns J; Mascarenhas M; Simões S; Tavares V; Lourenço O; da Silva JA
    Acta Reumatol Port; 2016; 41(4):305-321. PubMed ID: 27750276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted assessment of fracture risk in women at midlife.
    Davis SR; Tan A; Bell RJ
    Osteoporos Int; 2015 Jun; 26(6):1705-12. PubMed ID: 25630574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry.
    Leslie WD; Majumdar SR; Morin SN; Lix LM; Johansson H; Oden A; McCloskey EV; Kanis JA
    Osteoporos Int; 2017 Sep; 28(9):2557-2564. PubMed ID: 28593449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diabetes and osteoporosis].
    Ferrari S
    Rev Med Suisse; 2013 Jun; 9(390):1256, 1258-9. PubMed ID: 23821843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of the WHO fracture risk assessment tool (FRAX) to predict need for DEXA scanning and treatment in patients with inflammatory bowel disease at risk of osteoporosis.
    Goodhand JR; Kamperidis N; Nguyen H; Wahed M; Rampton DS
    Aliment Pharmacol Ther; 2011 Mar; 33(5):551-8. PubMed ID: 21198706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of bisphosphonates against osteoporosis in adult men: a meta-analysis of randomized controlled trials.
    Chen L; Wang G; Zheng F; Zhao H; Li H
    Osteoporos Int; 2015 Sep; 26(9):2355-63. PubMed ID: 25944731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of Trabecular Bone Score as a complementary approach to DXA for fracture risk assessment in clinical practice].
    Hans D; Shevroja E; Lamy O
    Rev Med Suisse; 2017 Apr; 13(559):844-850. PubMed ID: 28727341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Who is at risk of receiving inadequate care for osteoporosis following fragility fractures? A retrospective study.
    Blecher R; Wasrbrout Z; Arama Y; Kardosh R; Agar G; Mirovsky Y
    Isr Med Assoc J; 2013 Oct; 15(10):634-8. PubMed ID: 24266091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnostics, risk and indication for treatment of osteoporosis].
    Kindmark A; Salminen H
    Lakartidningen; 2016 Nov; 113():. PubMed ID: 27824392
    [No Abstract]   [Full Text] [Related]  

  • 37. Rationale of the Spanish FRAX model in decision-making for predicting osteoporotic fractures: an update of FRIDEX cohort of Spanish women.
    Azagra R; Zwart M; Encabo G; Aguyé A; Martin-Sánchez JC; Puchol-Ruiz N; Gabriel-Escoda P; Ortiz-Alinque S; Gené E; Iglesias M; Moriña D; Diaz-Herrera MA; Utzet M; Manresa JM;
    BMC Musculoskelet Disord; 2016 Jun; 17():262. PubMed ID: 27317560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone fragility in men: where are we?
    Nuti R; Merlotti D; Francucci CM; Gennari L
    J Endocrinol Invest; 2010; 33(7 Suppl):33-8. PubMed ID: 20938224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology and management of osteoporosis in the People's Republic of China: current perspectives.
    Lin X; Xiong D; Peng YQ; Sheng ZF; Wu XY; Wu XP; Wu F; Yuan LQ; Liao EY
    Clin Interv Aging; 2015; 10():1017-33. PubMed ID: 26150706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of bisphosphonates for prevention of fracture related to glucocorticoid-induced osteoporosis in Malaysia.
    Mohd-Tahir NA; Thomas P; Mohamed-Said MS; Makmor-Bakry M; Li SC
    Int J Rheum Dis; 2018 Mar; 21(3):647-655. PubMed ID: 29105349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.